Mission Statement
The mission of START is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. START consists of a team of highly trained physicians and staff with extensive experience in Phase I clinical trials research.
We Have Expanded!
We have expanded globally with the launch of START Madrid. The Madrid unit is led by Emiliano Calvo, M.D., Ph.D., Director of Clinical Research. He is joined by Ignacio Durán, M.D., Ph.D., Associate Director of Clinical Research, and Manuel Hidalgo, M.D., Ph.D., Director of the Centro Integral Oncológico Clara Campal. Drs. Calvo and Hidalgo trained with Dr. Tolcher in San Antonio, TX.
This International program is the first step in our goal to keep the development of anticancer agents operating 24 hours a day. Because of the work of scientists like those at START and START Madrid, real progress is being made against cancer. Through the hard work of these physicians and the continuing advances in technology we are able to improve the tools to understand, detect, and diagnose cancer. Today, people with cancer are living longer than ever before with a better quality of life.
Contact
Gina L. Mangold, MBA
Chief Operating Officer
Phone: (210) 593-5250
Fax: (210) 615-1121
E-mail: gina.mangold@start.stoh.com
|
|
4383 Medical Drive,
San Antonio, TX 78229
Directions
|
